ACR, Arthritis Foundation recommend against chronic glucocorticoids in JIA treatment

Health care providers should avoid prescribing chronic low-dose glucocorticoids — regardless of risk factors or disease activity — when treating children with juvenile idiopathic arthritis manifesting as non‐systemic polyarthritis, sacroiliitis or enthesitis, according to recommendations published in Arthritis Care & Research.
The American College of Rheumatology, in partnership with the Arthritis Foundation, released several recommendations in a pair of guidelines, one focused on therapeutic approaches for non‐systemic polyarthritis, sacroiliitis or enthesitis in JIA, and the

Full Story →